STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $357,000 | -35.2% | 73,768 | +42.3% | 0.00% | – |
| Q4 2019 | $551,000 | -66.5% | 51,823 | -67.2% | 0.00% | – |
| Q3 2019 | $1,643,000 | -81.5% | 157,792 | -72.8% | 0.00% | -100.0% |
| Q2 2019 | $8,890,000 | +333.2% | 580,454 | +263.5% | 0.00% | 0.0% |
| Q1 2019 | $2,052,000 | -45.8% | 159,700 | -59.9% | 0.00% | -50.0% |
| Q4 2018 | $3,783,000 | -19.6% | 398,137 | +40.5% | 0.00% | +100.0% |
| Q3 2018 | $4,704,000 | +27.9% | 283,351 | +23.6% | 0.00% | 0.0% |
| Q2 2018 | $3,679,000 | +137.2% | 229,265 | +126.1% | 0.00% | – |
| Q1 2018 | $1,551,000 | +5.6% | 101,400 | +7.7% | 0.00% | – |
| Q4 2017 | $1,469,000 | +39.2% | 94,179 | -0.9% | 0.00% | – |
| Q3 2017 | $1,055,000 | +41.8% | 95,014 | +17.4% | 0.00% | – |
| Q2 2017 | $744,000 | -55.7% | 80,900 | -58.8% | 0.00% | – |
| Q1 2017 | $1,678,000 | +59.7% | 196,246 | +99.8% | 0.00% | – |
| Q4 2016 | $1,051,000 | +518.2% | 98,222 | +525.6% | 0.00% | – |
| Q3 2016 | $170,000 | -36.3% | 15,700 | -72.5% | 0.00% | – |
| Q1 2016 | $267,000 | +276.1% | 57,188 | +406.0% | 0.00% | – |
| Q4 2015 | $71,000 | -89.6% | 11,303 | -85.4% | 0.00% | – |
| Q3 2015 | $685,000 | +333.5% | 77,605 | +477.7% | 0.00% | – |
| Q2 2015 | $158,000 | -7.1% | 13,433 | +14.3% | 0.00% | – |
| Q1 2015 | $170,000 | -19.0% | 11,750 | -4.7% | 0.00% | – |
| Q4 2014 | $210,000 | -52.1% | 12,328 | -64.9% | 0.00% | – |
| Q3 2014 | $438,000 | +111.6% | 35,143 | +232.5% | 0.00% | – |
| Q4 2013 | $207,000 | – | 10,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|